PCSK9 gene editing therapy (Aanastra)

N/A

Report date: 2025/08/13 16:51:10

Base Information

Drug NamePCSK9 gene editing therapy (Aanastra)
Drug Alias NameADGN-xxx-PCSK9ADGN-PCSK9
ClassificationCell and gene therapy > Gene therapy > Gene editing
Mechanisms of ActionProprotein convertase subtilisin kexin type 9 inhibitors
TargetsProprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAanastra Inc
China Registration ClassN/A

Develop Information

Active CompaniesAanastra Inc
Inactive CompaniesN/A
Active IndicationsHypercholesterolemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A